— Know what they know.
Not Investment Advice
Also trades as: RADCQ (OTC) · $vol 0M

RAD NYSE

Rite Aid Corporation
1W: +30.8% 1M: -54.0% 3M: -91.2% 1Y: -95.2% 3Y: -97.5% 5Y: -98.9%
$0.65
Last traded 2023-11-06 — delisted
NYSE · Healthcare · Medical - Pharmaceuticals · $36.8M mcap · 54M float · 15.08% daily turnover

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$24.1B -1.9% ▼
5Y CAGR: +2.3%
Gross Profit
$4.8B -5.9% ▼
5Y CAGR: +0.1%
Operating Income
-$98M -235.2% ▼
Net Income
-$750M -39.3% ▼
EPS (Diluted)
$-13.64 -36.9% ▼
EBITDA
-$31M -51.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$21.6B$21.9B$24.0B$24.6B$24.1B
YoY Growth+0.5%+1.3%+9.6%+2.2%-1.9%
Cost of Revenue$17.0B$17.2B$19.3B$19.5B$19.3B
Gross Profit$4.7B$4.7B$4.7B$5.1B$4.8B
Gross Margin21.6%21.6%19.6%20.8%19.9%
R&D Expenses$0$0$0$0$0
SG&A Expenses$4.6B$4.6B$4.7B$5.0B$4.9B
Operating Expenses$4.6B$4.6B$4.7B$5.0B$4.9B
Operating Income$84M$139M$47M$73M-$98M
Operating Margin0.4%0.6%0.2%0.3%-0.4%
Interest Expense$228M$230M$201M$192M$224M
Income Before Tax-$589M-$82M-$120M-$542M-$756M
Tax Expense$77M$388M-$20M-$4M-$6M
Net Income-$422M-$469M-$100M-$538M-$750M
Net Margin-2.0%-2.1%-0.4%-2.2%-3.1%
EPS (Diluted)$-7.99$-8.82$-1.87$-9.96$-13.64
EBITDA$224M$706M$374M$137M-$31M
Shares Outstanding53M53M54M54M55M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms